Commercial embodiments of genetically modified inventions are protected in Canada.
Jane E. Clark, BSU
Advertisement
Articles by Jane E. Clark, BSU
Biotech patent decisions before the Supreme Court and the Prime Minister's commitment to innovation will shape the future of life sciences protection in Canada.
Advertisement
Latest Updated Articles
The State of Intellectual Property in Canada: Pending and SpendingFebruary 1st 2004
Advertisement
Advertisement
Trending on BioPharm International
1
Nuravax Alzheimer Vaccine AV-1959R Earns FDA Fast Track Designation
2
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
3
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
4
Geneos Launches Phase 2 IMPACT31 Trial of Personalized DNA Cancer Vaccine to Prevent Liver Cancer Recurrence
5